Promoter Hypermethylation of the Phosphatase DUSP22 Mediates PKA- Dependent TAU Phosphorylation and CREB Activation in Alzheimer's Disease

被引:89
作者
Vicente Sanchez-Mut, Jose [1 ]
Aso, Ester [2 ]
Heyn, Holger [1 ]
Matsuda, Tadashi [3 ]
Bock, Christoph [4 ]
Ferrer, Isidre [2 ]
Esteller, Manel [1 ,5 ,6 ]
机构
[1] Bellvitge Biomed Res Inst IDIBELL, Epigenet & Biol Program PEBC, Barcelona, Spain
[2] Univ Barcelona, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Hosp Univ Bellvitge, Neuropathol Inst,Bellvitge Biomed Res Inst IDIBEL, Barcelona, Catalonia, Spain
[3] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Sapporo, Hokkaido, Japan
[4] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria
[5] Univ Barcelona, Sch Med, Dept Physiol Sci 2, Barcelona, Catalonia, Spain
[6] Inst Catalana Recerca & Estudis Avancats, Barcelona, Catalonia, Spain
关键词
epigenetics; DNA methylation; hippocampus; brain and neurodegeneration; ELEMENT-BINDING PROTEIN; DNA METHYLATION; EPIGENETIC MODIFICATIONS; FRONTAL-CORTEX; MICE LACKING; EXPRESSION; NEURONS; TRANSCRIPTION; DEGENERATION; MECHANISMS;
D O I
10.1002/hipo.22245
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Genetic screening in Alzheimer's disease (AD) has identified only a handful of genes that are mutated in the disorder. Thus, for a very large proportion of patients, the biology of their disease is poorly understood. Epigenetic alterations may provide an explanation in these cases. Using DNA methylation profiles of human hippocampus from controls and patients, we have identified the presence of promoter hypermethylation of the dual-specificity phosphatase 22 (DUSP22) gene in AD. DUSP22 is a likely candidate gene for involvement in the pathogenesis of the disorder since, as we demonstrate here, it inhibits PKA activity and thereby determines TAU phosphorylation status and CREB signaling. (c) 2014 The Authors. Hippocampus Published by Wiley Periodicals, Inc.
引用
收藏
页码:363 / 368
页数:6
相关论文
共 27 条
  • [21] DNA Methylation in the Human Cerebral Cortex Is Dynamically Regulated throughout the Life Span and Involves Differentiated Neurons
    Siegmund, Kimberly D.
    Connor, Caroline M.
    Campan, Mihaela
    Long, Tiffany I.
    Weisenberger, Daniel J.
    Biniszkiewicz, Detlev
    Jaenisch, Rudolf
    Laird, Peter W.
    Akbarian, Schahram
    [J]. PLOS ONE, 2007, 2 (09):
  • [22] The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription
    Steffan, JS
    Kazantsev, A
    Spasic-Boskovic, O
    Greenwald, M
    Zhu, YZ
    Gohler, H
    Wanker, EE
    Bates, GP
    Housman, DE
    Thompson, LM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (12) : 6763 - 6768
  • [23] Assembly of allosteric macromolecular switches: lessons from PKA
    Taylor, Susan S.
    Ilouz, Ronit
    Zhang, Ping
    Kornev, Alexandr P.
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2012, 13 (10) : 646 - 658
  • [24] Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome
    Trivier, E
    DeCesare, D
    Jacquot, S
    Pannetier, S
    Zackai, E
    Young, I
    Mandel, JL
    SassoneCorsi, P
    Hanauer, A
    [J]. NATURE, 1996, 384 (6609) : 567 - 570
  • [25] Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation:: Reversibility by drugs that enhance cAMP signaling
    Vitolo, OV
    Sant'Angelo, A
    Costanzo, V
    Battaglia, F
    Arancio, O
    Shelanski, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (20) : 13217 - 13221
  • [26] Abnormal Hyperphosphorylation of Tau: Sites, Regulation, and Molecular Mechanism of Neurofibrillary Degeneration
    Wang, Jian-Zhi
    Xia, Yi-Yuan
    Grundke-Iqbal, Inge
    Iqbal, Khalid
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2013, 33 : S123 - S139
  • [27] Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type
    Yamamoto-Sasaki, M
    Ozawa, H
    Saito, T
    Rösler, M
    Riederer, P
    [J]. BRAIN RESEARCH, 1999, 824 (02) : 300 - 303